Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 7, 2014, Pages 1101-1111

  Millares, L ^a,b,c,d   Ferrari, R ^e,f,g   Gallego, M ^b,h   Garcia Nunez M ^a,b,d   Perez Brocal V ^e,f,g   Espasa, M ^h   Pomares, X ^h   Monton, C ^h   Moya, A ^e,f,g   Alonso E ^b,c,h  

^a Unit of Clinical Trials   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Germans Trias i Pujol Health Research Institute   (Spain)

^e Genomics and Health   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

^h Servei de Pneumologia Hospital Universitari Parc Taulí   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; RNA 16S; BACTERIAL DNA; RIBOSOME DNA;

ACHROMOBACTER; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BRONCHIAL MICROBIOME; BRONCHUS SECRETION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CORYNEBACTERIUM; DISEASE EXACERBATION; FEMALE; GENE AMPLIFICATION; HAEMOPHILUS; HUMAN; MALE; MICROBIAL DIVERSITY; MICROBIOME; MORAXELLA; NEISSERIA; POPULATION ABUNDANCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYROSEQUENCING; SPUTUM CULTURE; STREPTOCOCCUS; BRONCHUS; CHEMISTRY; CLUSTER ANALYSIS; COHORT ANALYSIS; DNA SEQUENCE; GENETICS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MOLECULAR GENETICS; PHYLOGENY; SPUTUM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRONCHI; CLUSTER ANALYSIS; COHORT STUDIES; DNA, BACTERIAL; DNA, RIBOSOMAL; FEMALE; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; SPUTUM;

EID: 84903815893     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-2044-0     Document Type: Article

References (44)

1. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA (2000) Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 109(4):288-295
2. Sethi S, Evans N, Grant BJ, Murphy TF (2002) New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 347(7):465-471 (Pubitemid 34879333)
3. Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, Hernandez C, Rodriguez-Roisin R (1998) Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157(5 Pt 1):1498-1505
4. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H (1998) Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 113(6):1542-1548 (Pubitemid 28307157)
5. Rosell A, Monso E, Soler N, Torres F, Angrill J, Riise G, Zalacain R, Morera J, Torres A (2005) Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 165(8):891-897 (Pubitemid 40563235)
6. Lieberman D (2003) Pseudomonal infections in patients with COPD: epidemiology and management. Am J Respir Med 2(6):459-468
7. Garcia-Vidal C, Almagro P, Romani V, Rodriguez-Carballeira M, Cuchi E, Canales L, Blasco D, Heredia JL, Garau J (2009) Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J 34(5):1072-1078
8. Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M (1999) Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 116(1):40-46 (Pubitemid 29340258)
9. Rakhimova E, Wiehlmann L, Brauer AL, Sethi S, Murphy TF, Tummler B (2009) Pseudomonas aeruginosa population biology in chronic obstructive pulmonary disease. J Infect Dis 200(12):1928-1935
10. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, Verheij TJ (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 26(6):1138-1180 (Pubitemid 41829947)
11. Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S (2008) Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177(8):853-860 (Pubitemid 351600663)
12. Martinez-Solano L, Macia MD, Fajardo A, Oliver A, Martinez JL (2008) Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis 47(12):1526-1533
13. Pomares X, Monton C, Espasa M, Casabon J, Monso E, Gallego M (2011) Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations. Int J Chron Obstruct Pulmon Dis 6:449-456
14. Murphy TF (2008) The many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Clin Infect Dis 47(12):1534-1536
15. Hayashi H, Sakamoto M, Benno Y (2002) Phylogenetic analysis of the human gutmicrobiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 46(8):535-548 (Pubitemid 34947852)
16. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65(11):4799-4807
17. Sibley CD, Grinwis ME, Field TR, Eshaghurshan CS, Faria MM, Dowd SE, Parkins MD, Rabin HR, Surette MG (2011) Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One 6(7):e22702
18. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG (2011) Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 184(8):957-963
19. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB (2011) Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One 6(2):e16384
20. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, Moffatt MF, Cookson WO (2010) Disordered microbial communities in asthmatic airways. PLoS One 5(1):e8578
21. Armougom F, Bittar F, Stremler N, Rolain JM, Robert C, Dubus JC, Sarles J, Raoult D, La Scola B (2009) Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing. Eur J Clin Microbiol Infect Dis 28(9):1151-1154
22. Updated 2013 Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. www.goldcopd.com
23. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106(2):196-204 (Pubitemid 17009877)
24. Canton R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, Garcia-Quetglas E (2005) Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect 11(9):690-703 (Pubitemid 41167334)
25. Vendrell M, de Gracia J, Olveira C, Martinez MA, Giron R, Maiz L, Canton R, Coll R, Escribano A, Sole A (2008) Diagnosis and treatment of bronchiectasis. Spanish Society of Pneumology and Thoracic Surgery. Arch Bronconeumol 44(11):629-640
26. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, Sahl JW, Stres B, Thallinger GG, Van Horn DJ, Weber CF (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75(23):7537-7541
27. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335-336
28. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, Huttenhower C (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12(6):R60
29. Chao A (1984) Nonparametric estimation of the number of classes in a population. Scand J Stat 11:265-270
30. Shannon CE (1997) The mathematical theory of communication. 1963. MD Comput 14(4):306-317
31. Bray JR, Curtis JT (1957) An ordination of the upland forest communities of southern Wisconsin. Ecol Monogr 27:325-349
32. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL, Flores SC, Fontenot AP, Ghedin E, Huang L, Jablonski K, Kleerup E, Lynch SV, Sodergren E, Twigg H, Young VB, Bassis CM, Venkataraman A, Schmidt TM, Weinstock GM (2013) Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 187(10):1067-1075
33. Curtis JL, Freeman CM, Hogg JC (2007) The immunopathogenesis of chronic obstructive pulmonary disease: insights from recent research. Proc Am Thorac Soc 4(7):512-521 (Pubitemid 47547845)
34. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, Roca J, Dore J (2006) Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55(2):205-211 (Pubitemid 43117279)
35. Sartor RB (2008) Therapeutic correction of bacterial dysbiosis discovered bymolecular techniques. Proc Natl Acad Sci U S A 105(43): 16413-16414
36. Frank DN, Zhu W, Sartor RB, Li E (2011) Investigating the biological and clinical significance of human dysbioses. Trends Microbiol 19(9):427-434
37. Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW (2001) Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183(3):444 -452
38. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL (2002) Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 34(2):91-100 (Pubitemid 34809519)
39. West SE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, Splaingard MJ, Farrell PM (2002) Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 287(22): 2958-2967 (Pubitemid 34619999)
40. Dal Negro R, Micheletto C, Tognella S, Visconti M, Turati C (2008) Tobramycin nebulizer solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation. Adv Ther 25(10):1019-1030
41. Orriols R, Roig J, Ferrer J, Sampol G, Rosell A, Ferrer A, Vallano A (1999) Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med 93(7):476-480 (Pubitemid 29364062)
42. Han MK, Huang YJ, Lipuma JJ, Boushey HA, Boucher RC, Cookson WO, Curtis JL, Erb-Downward J, Lynch SV, Sethi S, Toews GB, Young VB, Wolfgang MC, Huffnagle GB, Martinez FJ (2012) Significance of the microbiome in obstructive lung disease. Thorax 67(5):456-463
43. Morgan XC, Huttenhower C (2012) Chapter 12: Human microbiome analysis. PLoS Comput Biol 8(12):e1002808
44. Molyneaux PL, Mallia P, Cox MJ, Footitt J, Willis-Owen SA, Homola D, Trujillo-Torralbo MB, Elkin S, Kon OM, Cookson WO, Moffatt MF, Johnston SL (2013) Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188(10):1224-1231